Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients

被引:30
作者
Diamantopoulos, Marios A. [1 ]
Kontos, Christos K. [1 ]
Kerimis, Dimitrios [1 ]
Papadopoulos, Iordanis N. [2 ]
Scorilas, Andreas [1 ]
机构
[1] Univ Athens, Dept Biochem & Mol Biol, Athens 15701, Greece
[2] Univ Athens, Univ Gen Hosp Attikon, Surg Dept 4, Athens, Greece
关键词
colon cancer; microRNA-16 (miRNA-16); molecular tumor markers; prognosis; prognostic biomarkers; reverse-transcription quantitative real-time PCR (RT-qPCR); REAL-TIME PCR; MICROSATELLITE INSTABILITY; PROGNOSTIC-SIGNIFICANCE; MICRORNA SIGNATURES; SIGNALING PATHWAY; DOWN-REGULATION; CANCER PATIENTS; RECTAL-CANCER; TUMOR-MARKERS; CELLS;
D O I
10.1515/cclm-2016-0756
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Colorectal adenocarcinoma is one of the most common malignant tumors of the gastrointestinal tract and the second leading cause of cancer-related deaths among adults in Western countries. miR-16 is heavily involved in cancer progression. In this study, we examined the potential diagnostic and prognostic utility of miR-16 expression in colorectal adenocarcinoma. Methods: Total RNA was extracted from 182 colorectal adenocarcinoma specimens and 86 non-cancerous colorectal mucosae. After polyadenylation of 2 mu g total RNA by poly(A) polymerase and subsequent reverse transcription with an oligo-dT adapter primer, miR-16 expression was determined using an in-house developed reverse transcription quantitative real-time PCR method, based on SYBR Green chemistry. SNORD43 (RNU43) and SNORD48 (RNU48) were used as reference genes. Next, we performed extensive biostatistical analysis. Results: miR-16 was shown to be significantly upregulated in colorectal adenocarcinoma specimens compared to non-cancerous colorectal mucosae, suggesting its potential exploitation for diagnostic purposes. Moreover, high miR-16 expression predicts poor disease-free survival (DFS) and overall survival (OS) of colorectal adenocarcinoma patients. Multivariate Cox regression analysis confirmed that miR-16 overexpression is a significant unfavorable prognosticator in colorectal adenocarcinoma, independent of other established prognostic factors, radiotherapy, and chemotherapy. Interestingly, miR-16 overexpression retains its unfavorable prognostic value in patients with advanced yet locally restricted colorectal adenocarcinoma that has not grown through the wall of the colon or rectum (T3) and in those without distant metastasis (M0). Conclusions: Overexpression of the cancer-associated miR-16 predicts poor DFS and OS of colorectal adenocarcinoma patients, independently of clinicopathological factors that are currently used for prognostic purposes.
引用
收藏
页码:737 / 747
页数:11
相关论文
共 51 条
[1]   miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma [J].
Adamopoulos, Panagiotis G. ;
Kontos, Christos K. ;
Rapti, Stamatia-Maria ;
Papadopoulos, Iordanis N. ;
Scorilas, Andreas .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (02) :849-859
[2]   The impact of microRNAs on protein output [J].
Baek, Daehyun ;
Villen, Judit ;
Shin, Chanseok ;
Camargo, Fernando D. ;
Gygi, Steven P. ;
Bartel, David P. .
NATURE, 2008, 455 (7209) :64-U38
[3]   MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer [J].
Bhattacharya, Resham ;
Nicoloso, Milena ;
Arvizo, Rochelle ;
Wang, Enfeng ;
Cortez, Angelica ;
Rossi, Simona ;
Calin, George A. ;
Mukherjee, Priyabrata .
CANCER RESEARCH, 2009, 69 (23) :9090-9095
[4]   The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments [J].
Bustin, Stephen A. ;
Benes, Vladimir ;
Garson, Jeremy A. ;
Hellemans, Jan ;
Huggett, Jim ;
Kubista, Mikael ;
Mueller, Reinhold ;
Nolan, Tania ;
Pfaffl, Michael W. ;
Shipley, Gregory L. ;
Vandesompele, Jo ;
Wittwer, Carl T. .
CLINICAL CHEMISTRY, 2009, 55 (04) :611-622
[5]   MiR-15a and miR-16-1 cluster functions in human leukemia [J].
Calin, George A. ;
Cimmino, Amelia ;
Fabbri, Muller ;
Ferracin, Manuela ;
Wojcik, Sylwia E. ;
Shimizu, Masayoshi ;
Taccioli, Cristian ;
Zanesi, Nicola ;
Garzon, Ramiro ;
Aqeilan, Rami I. ;
Alder, Hansjuerg ;
Volinia, Stefano ;
Rassenti, Laura ;
Liu, Xiuping ;
Liu, Chang-gong ;
Kipps, Thomas J. ;
Negrini, Massimo ;
Croce, Carlo M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (13) :5166-5171
[6]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[7]   X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization [J].
Camp, RL ;
Dolled-Filhart, M ;
Rimm, DL .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7252-7259
[8]   Upregulated microRNA-16 as an oncogene in renal cell carcinoma [J].
Chen, Duqun ;
Li, Yifan ;
Yu, Zuhu ;
Su, Zhengming ;
Yu, Wenshui ;
Li, Yuchi ;
Yang, Shangqi ;
Gui, Yaoting ;
Ni, Liangchao ;
Lai, Yongqing .
MOLECULAR MEDICINE REPORTS, 2015, 12 (01) :1399-1404
[9]   Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma [J].
Christodoulou, Spyridon ;
Alexopoulou, Dimitra K. ;
Kontos, Christos K. ;
Scorilas, Andreas ;
Papadopoulos, Iordanis N. .
TUMOR BIOLOGY, 2014, 35 (05) :4673-4685
[10]   The staging of colorectal cancer: 2004 and beyond [J].
Compton, CC ;
Greene, FL .
CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (06) :295-308